Mississauga, ON -- (ReleaseWire) -- 05/06/2014 -- AllPennyStocks.com Media, Inc. (http://www.AllPennyStocks.com/) announces its latest article titled “BiOasis Technologies Transcend Platform Makes Breakthrough in RNAi Therapies.”
Companies mentioned in this article include Nuvilex, Inc. (OTCQB:NVLX), NanoAntibiotics, Inc. (OTCQB:NNAB), BiOasis Technologies Inc. (TSX-Venture:BTI) (OTCQX:BIOAF) and AstraZeneca (NYSE:AZN).
Investors sometimes focus only on new drugs and ignore the importance of new drug delivery technologies that can rejuvenate and improve existing drugs to treat many diseases representing areas of great unmet medical need. Innovation comes in many forms and deviating from conventional thinking could be the passe-partout to a new wave of effective treatments for deadly and debilitating diseases of today. There are many different approaches, each of which is promising in its own right to bring new therapeutics to market. To name just a few, there are cell encapsulation technologies, of Nuvilex, Inc. (OTCQB:NVLX) being advanced in clinical trials for pancreatic cancer and nanotechnologies of newly-public NanoAntibiotics, Inc. (OTCQB:NNAB) that are targeting inhibiting bacteria’s efflux pumps to address the growing problem of antibiotic resistance and superbugs.
Vancouver-based BiOasis Technologies Inc. (TSX-Venture:BTI) (OTCQX:BIOAF) is focused on the blood-brain barrier to tackle brain diseases such as neurodegeneration, metastatic cancer and metabolic diseases. The company’s flagship product, dubbed “Transcend,” is a proprietary protein vector that allows existing drugs to be shuttled across the blood-brain barrier.
The full version of this article can be found at:
AllPennyStocks.com is focused on the small-cap / penny stock market and has become a reputable name in the investment community. AllPennyStocks.com runs a Canadian and US site to provide investors in Canada as well as the United States with informative and unique content and information. AllPennyStocks.com runs daily technical penny stocks to watch, has a daily market write-up, provides company spotlights, runs unique most active pages strictly for penny stocks trading on the TSX, TSX Venture, NASDAQ and OTC BB, and much more information for the average investor.
AllPennyStocks.com also runs an email newsletter that aims to uncover stocks that are still under the radar of most investors. Criteria AllPennyStocks.com looks for includes strong revenues, a seasoned management, innovative business plans, among many others. AllPennyStocks.com also looks for companies that announce breaking news, recent 52-week highs/lows, technical breakouts, and other favorable corporate information.
Investors are encouraged to subscribe to the AllPennyStocks.com FREE e-mail newsletter and see what tens of thousands of other investors have already been receiving since 1999. Investors can receive their free newsletter subscription by clicking here: http://www.allpennystocks.com/aps_common/newsletter_free.asp.
AllPennyStocks.com Media, Inc.
Peter Szafranski -- President
Phone: (905) 361-5680
Websites: http://www.allpennystocks.com / http://www.bullishinvestor.com
Note: AllPennyStocks.com has not received compensation for carrying the above-mentioned company; a full disclaimer can be viewed here: http://www.allpennystocks.com/aps_common/disclaimer.asp.